Given the fact that it has been associated with cancer progression and invasiveness (Wu & Zhu, 2015), we wondered whether the expression of LOXL2 could be used to predict tumor response to standard chemotherapeutic drugs. This evidence concerns the gene LOXL2 and cancer.